Mkts

Estrella Immunopharma, Inc.

NASDAQ: ESLA
$0.51+0.00 (-0.94%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
0.460.55
52-week range
0.242.71
Today
Open0.52
Previous close0.51
Volume4.24M
Valuation
Market cap22.36M
P/E ratio—
EPS (TTM)-0.25
Income & risk
Dividend / yield—
Beta0.91
Avg volume1.42M
Discussion

ESLA News

Stories mentioning ESLA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q3 '24Sep 30Q2 '24Jun 30Q1 '24Mar 31
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development1,40026.004,1534,6601,4102,8263,52525.00
Sales General & Admin
Total Operating Expenses2,292614.004,8015,5442,1043,3773,949470.00
Operating Income (Loss)(2,292)(614.00)(4,801)(5,544)(2,104)(3,377)(3,949)(470.00)
Interest Income
Interest Expense
Other Expense
Pretax Income(2,292)(614.00)(4,801)(5,544)(2,104)(3,377)(3,949)(470.00)
Tax Provision1.000.002.00
Net Income (Loss)(2,292)(614.00)(4,801)(5,545)(2,104)(3,377)(3,951)(470.00)
Earnings Per Share (Basic)(0.05)(0.02)(0.13)(0.15)(0.06)(0.09)(0.11)(0.01)
Earnings Per Share (Diluted)(0.05)(0.02)(0.13)(0.15)(0.06)(0.09)(0.11)(0.01)
Weighted Average Shares Outstanding (Basic)42,12136,82137,09636,16636,18836,20836,37735,519
Weighted Average Shares Outstanding (Diluted)42,12136,82137,09636,16636,18836,20836,37735,519

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ESLA

Estrella Immunopharma, Inc. (NASDAQ: ESLA) is a stock listed on the Nasdaq Stock Market under the ticker symbol ESLA. It last traded at $0.5100 (Nov 13, 2026, 4:00 PM ET), down 0.9% on the day. That gives Estrella Immunopharma a market capitalisation of $22.4M.

Over the past 52 weeks ESLA has traded between $0.2400 and $2.71.

For the quarter ended Mar 31, 2026 it reported a net loss of $2.3M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$2.3M
Dec 31, 2025—-$614.0K
Sep 30, 2025—-$4.8M
Jun 30, 2025—-$5.5M

From Estrella Immunopharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…